annual shareholders equity:
$750.11M+$214.81M(+40.13%)Summary
- As of today (September 16, 2025), AKRO annual stockholders equity is $750.11 million, with the most recent change of +$214.81 million (+40.13%) on December 31, 2024.
- During the last 3 years, AKRO annual shareholders equity has risen by +$581.00 million (+343.57%).
- AKRO annual shareholders equity is now at all-time high.
Performance
AKRO Shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly shareholders equity:
$1.03B-$58.03M(-5.35%)Summary
- As of today (September 16, 2025), AKRO quarterly stockholders equity is $1.03 billion, with the most recent change of -$58.03 million (-5.35%) on June 30, 2025.
- Over the past year, AKRO quarterly shareholders equity has increased by +$227.75 million (+28.54%).
- AKRO quarterly shareholders equity is now -5.35% below its all-time high of $1.08 billion, reached on March 31, 2025.
Performance
AKRO quarterly shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Shareholders equity Formula
Shareholders Equity = Total Assets − Total Liabilities
AKRO Shareholders equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +40.1% | +28.5% |
| 3 y3 years | +343.6% | +591.4% |
| 5 y5 years | +482.7% | +889.6% |
AKRO Shareholders equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +343.6% | -5.3% | +591.4% |
| 5 y | 5-year | at high | +482.7% | -5.3% | +889.6% |
| alltime | all time | at high | >+9999.0% | -5.3% | >+9999.0% |
AKRO Shareholders equity History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $1.03B(-5.4%) |
| Mar 2025 | - | $1.08B(+44.5%) |
| Dec 2024 | $750.11M(+40.1%) | $750.11M(+1.6%) |
| Sep 2024 | - | $738.33M(-7.5%) |
| Jun 2024 | - | $798.07M(-5.7%) |
| Mar 2024 | - | $846.25M(+58.1%) |
| Dec 2023 | $535.31M(+63.9%) | $535.31M(-8.2%) |
| Sep 2023 | - | $583.13M(-5.4%) |
| Jun 2023 | - | $616.44M(+101.2%) |
| Mar 2023 | - | $306.35M(-6.2%) |
| Dec 2022 | $326.56M(+93.1%) | $326.56M(-4.9%) |
| Sep 2022 | - | $343.51M(+131.5%) |
| Jun 2022 | - | $148.37M(+1.3%) |
| Mar 2022 | - | $146.53M(-13.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $169.11M(-34.6%) | $169.11M(-14.9%) |
| Sep 2021 | - | $198.63M(-9.8%) |
| Jun 2021 | - | $220.13M(-10.5%) |
| Mar 2021 | - | $246.02M(-4.9%) |
| Dec 2020 | $258.71M(+101.0%) | $258.71M(-9.7%) |
| Sep 2020 | - | $286.46M(+176.3%) |
| Jun 2020 | - | $103.66M(-12.4%) |
| Mar 2020 | - | $118.32M(-8.1%) |
| Dec 2019 | $128.73M(+72.1%) | $128.73M(-10.2%) |
| Sep 2019 | - | $143.38M(-9.5%) |
| Jun 2019 | - | $158.39M(+127.4%) |
| Mar 2019 | - | $69.66M(-6.9%) |
| Dec 2018 | $74.81M(>+9900.0%) | $74.81M(>+9900.0%) |
| Dec 2017 | $436.00K | - |
| Dec 2017 | - | $436.00K |
FAQ
- What is Akero Therapeutics, Inc. annual stockholders equity?
- What is the all time high annual shareholders equity for Akero Therapeutics, Inc.?
- What is Akero Therapeutics, Inc. annual shareholders equity year-on-year change?
- What is Akero Therapeutics, Inc. quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Akero Therapeutics, Inc.?
- What is Akero Therapeutics, Inc. quarterly shareholders equity year-on-year change?
What is Akero Therapeutics, Inc. annual stockholders equity?
The current annual shareholders equity of AKRO is $750.11M
What is the all time high annual shareholders equity for Akero Therapeutics, Inc.?
Akero Therapeutics, Inc. all-time high annual stockholders equity is $750.11M
What is Akero Therapeutics, Inc. annual shareholders equity year-on-year change?
Over the past year, AKRO annual stockholders equity has changed by +$214.81M (+40.13%)
What is Akero Therapeutics, Inc. quarterly stockholders equity?
The current quarterly shareholders equity of AKRO is $1.03B
What is the all time high quarterly shareholders equity for Akero Therapeutics, Inc.?
Akero Therapeutics, Inc. all-time high quarterly stockholders equity is $1.08B
What is Akero Therapeutics, Inc. quarterly shareholders equity year-on-year change?
Over the past year, AKRO quarterly stockholders equity has changed by +$227.75M (+28.54%)